Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 7/20 | 0.51 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.36 |
| ▸ | STK4 | Q13043 | 2/20 | 0.36 |
| ▸ | STK3 | Q13188 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21814339 | 0.94 | HTT (0.58) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL5019515 | 0.90 | HTT (0.41) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL4572187 | 0.83 | HTT (0.45) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL4569238 | 0.82 | HTT (0.36) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL5019519 | 0.79 | HSD17B10 (0.39) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL2623139 | 0.79 | MAPT (0.55) | HTTSMN1; SMN2TSHRNPC1RAB9A | |
| SCHEMBL4572189 | 0.77 | HTT (0.40) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| SCHEMBL9193680 | 0.76 | SLC6A2 (0.41) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 | |
| Dimethyladenine SCHEMBL152593 | 0.74 | LRRK2 (0.52) | HTTMAP3K5STK4STK3ADORA2A | |
| SCHEMBL29804812 | 0.74 | HTT (0.36) | HTTMAP3K5SMN1; SMN2NCOA1NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122838-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | INFINITY PHARMACEUTICALS, INC. | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122838-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | PIK3CA, PIK3CD, PIK3CB | HTT 823/4885MAP3K5 53/4885SMN1; SMN2 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.